Watermark
  Back to Search Results

BGB-A317-ZW25-101

Completed

Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-ZW25-101

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04276493

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20210237

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan